Anticipated Shortage

APO-CAPTO TAB 12.5MG

APOTEX INC

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-CAPTO TAB 12.5MG in Canada?

A shortage of APO-CAPTO TAB 12.5MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated June 15, 2026), but it has not started yet.

Why is APO-CAPTO TAB 12.5MG not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-CAPTO TAB 12.5MG be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusAnticipated Shortage

Same-ingredient products on file6 products

Affected strength12.5MG

Last updated2026-06-15

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

CAPOTEN TAB 12.5MG

BRISTOL-MYERS SQUIBB CANADA

12.5MG · DIN 00695661

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

CAPTOPRIL-12.5 TAB 12.5MG

PRO DOC LIMITEE

12.5MG · DIN 01910329

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

NU-CAPTO TAB 12.5MG

NU-PHARM INC

12.5MG · DIN 01913824

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

RATIO-CAPTOPRIL TAB 12.5MG

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

12.5MG · DIN 00851639

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MED CAPTOPRIL - TAB 12.5MG

MEDICAN PHARMA INCORPORATED

12.5MG · DIN 02188929

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

CAPOTEN TAB 25MG

BRISTOL-MYERS SQUIBB CANADA

25MG · DIN 00546283

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

00893595

Strength

12.5MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

CAPTOPRIL

Tier

Unrated

Last Updated

2026-06-15

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244

10MG · DIN 02240414

20MG · DIN 02296098

150MG · DIN 02296160

75MG · DIN 02230507

2MG · DIN 02554194

2MG · DIN 02554178